Market closed
Abpro Holdings/$ABP
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Abpro Holdings
Abpro Holdings Inc is a biotechnology company dedicated to developing next-generation antibody therapeutics with the goal of improving the lives of patients with severe and life-threatening diseases. It is focused on novel antibody constructs for immuno-oncology and ophthalmology. By leveraging its proprietary DiversImmune and MultiMabTM antibody discovery and engineering platforms. The company is developing a pipeline of next-generation antibodies, both independently and through collaborations with pharmaceutical and research institutions.
Ticker
$ABP
Sector
Trading on
Industry
Biotechnology
Headquarters
Employees
11
ISIN
US0008471031
Website
Abpro Holdings Metrics
BasicAdvanced
$12M
-
-$0.70
-
-
Price and volume
Market cap
$12M
52-week high
$0.73
52-week low
$0.15
Average daily volume
14M
Financial strength
Current ratio
0.108
Quick ratio
0.077
Total debt to equity
-18.236
Interest coverage (TTM)
-9.24%
Management effectiveness
Return on assets (TTM)
-212.91%
Return on equity (TTM)
81.55%
Valuation
Price to revenue (TTM)
39.397
Price to book
-0.64
Price to tangible book (TTM)
-0.63
Price to free cash flow (TTM)
-0.912
Growth
Revenue change (TTM)
88.66%
Earnings per share change (TTM)
73.97%
Abpro Holdings News
AllArticlesVideos
Abpro and Celltrion Unveil Preclinical Data for ABP-102/CT-P72 at AACR 2025, Showcasing Potential Best-in-Class HER2 x CD3 T-Cell Engager
GlobeNewsWire·3 weeks ago
Abpro Announces Oral Presentation of First Preclinical Data for ABP-102/CT-P72, a Tetravalent Bispecific HER2 x CD3 T-Cell Engager, at AACR Annual Meeting 2025
GlobeNewsWire·2 months ago
Abpro Statement on the Departure of Former CEO Ian Chan
GlobeNewsWire·2 months ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
FAQs
What’s the current market cap for Abpro Holdings stock?
Abpro Holdings (ABP) has a market cap of $12M as of May 18, 2025.
What is the P/E ratio for Abpro Holdings stock?
The price to earnings (P/E) ratio for Abpro Holdings (ABP) stock is 0 as of May 18, 2025.
Does Abpro Holdings stock pay dividends?
No, Abpro Holdings (ABP) stock does not pay dividends to its shareholders as of May 18, 2025.
When is the next Abpro Holdings dividend payment date?
Abpro Holdings (ABP) stock does not pay dividends to its shareholders.
What is the beta indicator for Abpro Holdings?
Abpro Holdings (ABP) does not currently have a Beta indicator.